JP2024537774A5 - - Google Patents
Info
- Publication number
- JP2024537774A5 JP2024537774A5 JP2024519284A JP2024519284A JP2024537774A5 JP 2024537774 A5 JP2024537774 A5 JP 2024537774A5 JP 2024519284 A JP2024519284 A JP 2024519284A JP 2024519284 A JP2024519284 A JP 2024519284A JP 2024537774 A5 JP2024537774 A5 JP 2024537774A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- subject
- amount
- risk
- developing sepsis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21199905.7 | 2021-09-29 | ||
| EP21199905 | 2021-09-29 | ||
| PCT/EP2022/077015 WO2023052446A1 (en) | 2021-09-29 | 2022-09-28 | Mr-proadm marker panels for early detection of sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537774A JP2024537774A (ja) | 2024-10-16 |
| JP2024537774A5 true JP2024537774A5 (https=) | 2025-09-24 |
Family
ID=78211828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519284A Pending JP2024537774A (ja) | 2021-09-29 | 2022-09-28 | 敗血症の早期検出のためのＭＲ－ｐｒｏＡＤＭマーカーパネル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250035629A1 (https=) |
| EP (1) | EP4409038A1 (https=) |
| JP (1) | JP2024537774A (https=) |
| CN (1) | CN118043479A (https=) |
| WO (1) | WO2023052446A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006445A1 (en) | 1997-07-31 | 1999-02-11 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-15 |
| JP2002543841A (ja) | 1999-05-17 | 2002-12-24 | バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー | ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性 |
| CA2476597C (en) | 2002-02-28 | 2011-05-17 | Metanomics Gmbh & Co. Kgaa | Mass spectrometry method for analysing mixtures of substances |
| WO2005113585A2 (en) | 2004-05-20 | 2005-12-01 | Acceleron Pharma Inc. | Modified tgf-beta superfamily polypeptides |
| US20090197794A1 (en) * | 2005-07-13 | 2009-08-06 | Aird William C | Methods of Diagnosing and Treating an Inflammatory Response |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| RU2016112915A (ru) | 2013-09-05 | 2017-10-09 | Эф-Ай-Оу Корпорейшн | Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение |
| US20190178897A1 (en) * | 2016-08-09 | 2019-06-13 | B.R.A.H.M.S Gmbh | Histones and/or proadm as markers indicating organ dysfunction |
-
2022
- 2022-09-28 JP JP2024519284A patent/JP2024537774A/ja active Pending
- 2022-09-28 US US18/696,730 patent/US20250035629A1/en active Pending
- 2022-09-28 CN CN202280066002.3A patent/CN118043479A/zh active Pending
- 2022-09-28 WO PCT/EP2022/077015 patent/WO2023052446A1/en not_active Ceased
- 2022-09-28 EP EP22798075.2A patent/EP4409038A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chandarana et al. | Visceral adipose tissue in patients with COVID-19: risk stratification for severity: H. Chandarana et al. | |
| Kamath et al. | A model to predict survival in patients with end‐stage liver disease | |
| JP6595984B2 (ja) | 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法 | |
| Lee et al. | Biomarkers for Recurrent Wheezing and Asthma in Preschool Children. | |
| Zink et al. | Segmental bioelectrical impedance spectroscopy to monitor fluid status in heart failure | |
| Ondruschka et al. | Post-mortem in situ stability of serum markers of cerebral damage and acute phase response | |
| Lee et al. | Clinical findings and outcomes in patients with possible usual interstitial pneumonia | |
| Makaryus et al. | Falsely elevated cardiac troponin I levels | |
| JP2024516678A5 (https=) | ||
| De Jager et al. | Procalcitonin kinetics in Legionella pneumophila pneumonia | |
| JP2024516680A5 (https=) | ||
| JP2024516677A5 (https=) | ||
| Kollert et al. | The impact of gas exchange measurement during exercise in pulmonary sarcoidosis | |
| RU2754776C1 (ru) | Способ клинико-лабораторного прогнозирования тяжести covid-19 | |
| JP2024537774A5 (https=) | ||
| RU2020127365A (ru) | Способы, применения и комплекты для диагностики пародонтита | |
| WO2003039349A2 (en) | Method of using physiological markers to estimate cardiovascular risk | |
| JP2024516001A5 (https=) | ||
| JP2024515086A5 (https=) | ||
| JP2024516681A5 (https=) | ||
| JP2024516679A5 (https=) | ||
| JP2024516665A5 (https=) | ||
| WO2024154832A1 (ja) | 全身性強皮症の検出方法 | |
| CN115586342B (zh) | 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置 | |
| Joshi et al. | C-reactive protein levels in acute pancreatitis and its prognostic significance |